Suchergebnisse - "Cook, Gordon"

PubPharm (409)

41

Primary graft failure, but not relapse, may be identified by early chimerism following double cord blood unit transplantation

enthalten in: Blood advances | 2022

von Hough, R. | Lopes, A. | Patrick, P. | +14

42

Impact of Etiological Cytogenetic Abnormalities on the Depth of Immunoparesis and Survival in Newly Diagnosed Multiple Myeloma

enthalten in: Clinical lymphoma, myeloma & leukemia | 2022

von Caro, J. | Cairns, D. | Menzies, T. | +11

43

Daratumumab plus lenalidomide and dexamethasone in transplant-ineligible newly diagnosed multiple myeloma : frailty subgroup analysis of MAIA

enthalten in: Leukemia | 2022

von Facon, T. | Cook, G. | Usmani, S. | +25

44

Ixazomib with cyclophosphamide and dexamethasone in relapsed or refractory myeloma : MUKeight phase II randomised controlled trial results

enthalten in: Blood cancer journal | 2022

von Auner, H. | Brown, S. | Walker, K. | +9

45

Key findings from the UKCCMP cohort of 877 patients with haematological malignancy and COVID-19 : disease control as an important factor relative to recent chemotherapy or anti-CD20 therapy

enthalten in: British journal of haematology | 2022

von Booth, S. | Curley, H. | Varnai, C. | +33

46

Redefining nonmeasurable multiple myeloma using mass spectrometry

enthalten in: Blood | 2022

von Giles, H. | Cook, M. | Drayson, M. | +12

47

Outcomes of relapse in patients with deferred autologous stem cell transplant after achieving at least very good partial response following bortezomib, adriamycin, dexamethasone chemotherapy for newly diagnosed multiple myeloma in the phase II PADIMAC trial

enthalten in: British journal of haematology | 2022

von Chan, W. | Counsell, N. | de Tute, R. | +24

48

Sustained minimal residual disease negativity in newly diagnosed multiple myeloma and the impact of daratumumab in MAIA and ALCYONE

enthalten in: Blood | 2022

von San-Miguel, J. | Avet-Loiseau, H. | Paiva, B. | +24

CommentIn: Blood. 2022 Jan 27;139(4):469-471. - PMID 35084473

49

COVID symptoms, testing, shielding impact on patient-reported outcomes and early vaccine responses in individuals with multiple myeloma

enthalten in: British journal of haematology | 2022

von Ramasamy, K. | Sadler, R. | Jeans, S. | +15

50

Autologous stem cell transplantation is safe and effective for fit older myeloma patients : exploratory results from the Myeloma XI trial

enthalten in: Haematologica | 2022

von Pawlyn, C. | Cairns, D. | Menzies, T. | +11